DIA Global 2018: Value Pricing Bootcamp: A Crash Course in How to Use Real World Evidence to Better Measure Outcomes and Evaluate New Innovative Therapies
24 June 2018 1:00 PM – 4:30 PM
Boston Convention and Exhibition Center
This Short Course will outline how best to harness RWE to better understand the price, value, and impact of next generation therapies.
Instructors
Luca Pani
University of Miami
Former Director General Italian Medicines Agency (AIFA)
Duane Schulthess
Managing Director
Vital Transformation
Contributors
Amr Makady
Pharmacoeconomics Advisor
Zorginstituut Nederland
Brian Rothman
Senior Director, Office of the Chief Health Information Officer
Vanderbilt University
Anna Ludlow
Project Manager
Vital Transformation
Julian Raffoul
Clinical Scientist
Nashville Biosciences
Daniel Gassull
Research Partner
Vital Transformation
The session will feature:
- Pricing and value case studies based on current clinical therapies such as CAR-T, IO Checkpoint, and HEP C
- Interactive workshop discussions on various payment options such as annuity, up front, or pay on performance
- An overview of the Italian outcomes system of reimbursement and how it has impacted price and access
- Real-time cost and outcomes modeling to test and aid discussions on various options to stakeholders
- Horizon scanning discussions on the impact of cures in areas such as Duchene Muscular Dystrophy, Viral Therapies, or Alzheimer’s which may arrive in 3-5 years: How can we plan now? What should we do differently?
Learning Objectives: This session will address the pricing, value, and access challenges being caused by highly effective targeted therapies such as IO Checkpoint, CAR-T, and Gene Therapies.